Literature DB >> 8283197

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

E F Juniper1, G H Guyatt, A Willan, L E Griffith.   

Abstract

This study was carried out to determine whether the minimal important difference, in evaluative quality of life instruments which use a 7-point scale, is similar across individual domains and for both improvement and deterioration. Thirty nine adults with asthma were studied, using an 8 week cohort with assessments at 0, 4 and 8 weeks. The outcomes were the Asthma Quality of Life Questionnaire and global rating of change. For overall asthma-specific quality of life and for all individual domains (activities, emotions, symptoms), the minimal important difference of quality of life score per item was very close to 0.5 (range: 0.42-0.58); differences of approximately 1.0 represented a moderate change (range: 0.77-1.51); differences greater than 1.5 represented large changes. Changes for improvement and deterioration were very similar. The changes in quality of life score that represent a minimal important difference are very similar to those observed for other evaluative instruments. The observation that the minimal important difference is consistent across domains and for both improvement and deterioration will facilitate interpretation of results of studies examining quality of life.

Entities:  

Mesh:

Year:  1994        PMID: 8283197     DOI: 10.1016/0895-4356(94)90036-1

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  419 in total

1.  Swedish population health-related quality of life results using the EQ-5D.

Authors:  K Burström; M Johannesson; F Diderichsen
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

2.  The MacNew heart disease health-related quality of life instrument: reference data for users.

Authors:  Tracy Dixon; Lynette L Y Lim; Neil B Oldridge
Journal:  Qual Life Res       Date:  2002-03       Impact factor: 4.147

3.  Using the standard error of measurement to identify important changes on the Asthma Quality of Life Questionnaire.

Authors:  Kathleen W Wyrwich; William M Tierney; Fredric D Wolinsky
Journal:  Qual Life Res       Date:  2002-02       Impact factor: 4.147

Review 4.  Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II.

Authors:  G Samsa; D Edelman; M L Rothman; G R Williams; J Lipscomb; D Matchar
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

5.  Reassessing quality-of-life instruments in the evaluation of new drugs.

Authors:  G H Guyatt; R J Jaeschke
Journal:  Pharmacoeconomics       Date:  1997-12       Impact factor: 4.981

6.  Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma.

Authors:  D B Price; D Hernandez; P Magyar; J Fiterman; K M Beeh; I G James; S Konstantopoulos; R Rojas; J A van Noord; M Pons; L Gilles; J A Leff
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

7.  On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation.

Authors:  C B Terwee; F W Dekker; W M Wiersinga; M F Prummel; P M M Bossuyt
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

8.  Accessibility, clinical effectiveness, and practice costs of providing a telephone option for routine asthma reviews: phase IV controlled implementation study.

Authors:  Hilary Pinnock; Lorraine Adlem; Suzanne Gaskin; Jan Harris; Caroline Snellgrove; Aziz Sheikh
Journal:  Br J Gen Pract       Date:  2007-09       Impact factor: 5.386

Review 9.  Bronchial thermoplasty for moderate or severe persistent asthma in adults.

Authors:  Alfons Torrego; Ivan Solà; Ana Maria Munoz; Marta Roqué I Figuls; Juan Jose Yepes-Nuñez; Pablo Alonso-Coello; Vicente Plaza
Journal:  Cochrane Database Syst Rev       Date:  2014-03-03

Review 10.  Clinically important changes in health-related quality of life for patients with chronic obstructive pulmonary disease: an expert consensus panel report.

Authors:  Kathleen W Wyrwich; Stephan D Fihn; William M Tierney; Kurt Kroenke; Ajit N Babu; Fredric D Wolinsky
Journal:  J Gen Intern Med       Date:  2003-03       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.